Aurora Cannabis, Canopy Growth, Tilray, Gibraltar Industries, and Turning Point Brands are the five Cannabis stocks to watch ...

Canopy’s stock reversed on earnings after seeing a rally sparked by the possibility of marijuana reform in the U.S.

Alliance Global Partners analyst Aaron Grey lowered the firm’s price target on Canopy Growth (CGC) to C$4 from C$7 and keeps a Neutral rating ...

Luc Mongeau, the newly appointed CEO, emphasized his commitment to advancing Canopy Growth toward sustained profitability and positive cash generation. He highlighted strengths in the medical cannabis ...

Canopy Growth Corporation ( NASDAQ: CGC) Q3 2025 Earnings Conference Call February 7, 2025 10:00 AM ET Aaron Grey - Alliance Global Partners Bill Kirk - ROTH Capital Partners Matt Bottomley - ...

Strong holiday sales drove Storz & Bickel net revenue growth of 19% year-over-year Record quarter for Canada medical cannabis with net revenue increasing 16%; international ...

Shares in Canopy Growth fell sharply Friday morning after the company's loss missed expectations in the fiscal third quarter. Shares fell over 18% to 3.27 Canadian dollars ($2.29).

Cloudflare shares traded sharply higher on Friday after its fourth-quarter earnings topped analyst expectations. Monitor ...

Canopy Growth Q3 sales hit C$74.76 million, surpassing estimates. Medical cannabis revenue rose 16%, while adjusted EBITDA loss improved 61% year-over-year.

Canadian cannabis producer cuts debt load and shows revenue growth in key segments while pushing ahead with U.S. expansion.

Canopy Growth (CGC) delivered earnings and revenue surprises of -58.33% and 12.06%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?